While reporting financial results for the third quarter on Thursday, medical company Danaher Corp. (DHR) said it anticipates adjusted core revenue growth for the fourth quarter, including Cytiva, to be in the low-double digit range.
from RTT - Earnings https://ift.tt/2TtFrOR
via IFTTT
No comments:
Post a Comment